Therapeutic advances in anaplastic thyroid cancer: a current perspective.

Saini, Shikha; Tulla, Kiara; Maker, Ajay V; Burman, Kenneth D; Prabhakar, Bellur S

Saini, Shikha; Tulla, Kiara; Maker, Ajay V; Burman, Kenneth D; Prabhakar, Bellur S.

Affiliation

Saini S; Department of Microbiology and Immunology, University of Illinois-College of Medicine, Chicago, IL, USA.
Tulla K; Department of Surgery, Division of Surgical Oncology, University of Illinois-College of Medicine, Chicago, IL, USA.
Maker AV; Department of Microbiology and Immunology, University of Illinois-College of Medicine, Chicago, IL, USA.
Burman KD; Department of Surgery, Division of Surgical Oncology, University of Illinois-College of Medicine, Chicago, IL, USA.
Prabhakar BS; MedStar Washington Hospital Medical Center, Washington, DC, USA.

Mol Cancer ; 17(1): 154, 2018 10 23.

Article in En | MEDLINE | ID: mdl-30352606

Subject(s)

Thyroid Carcinoma, Anaplastic/therapy; Animals; Combined Modality Therapy; Disease Management; Humans; Thyroid Carcinoma, Anaplastic/diagnosis; Thyroid Carcinoma, Anaplastic/etiology; Thyroid Carcinoma, Anaplastic/mortality; Treatment Outcome

Key words

Anaplastic thyroid Cancer; Clinical trial; Immunotherapy; Inhibitors; Therapeutics; Tumor

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thyroid Carcinoma, Anaplastic Type of study: Diagnostic_studies / Etiology_studies Limits: Animals / Humans Language: En Journal: Mol Cancer Journal subject: NEOPLASIAS Year: 2018 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google